You are not a
smaller man.
Every app on the App Store was designed for a body you don’t have. Steady is the correction.
MyFitnessPal wasn’t written for this moment.
Generic trackers were built in a world before GLP-1s. They assume willpower is the variable. They reward calorie deficits and punish “cheat days.” They treat a plateau as a personal failing and a week of nausea as an opportunity to skip meals.
You are on a medication that removes your appetite whether you want it removed or not. You are trying to protect muscle you cannot feel disappearing. You are noticing side effects that come and go with a rhythm no one has told you is real. A generic calorie counter is, at best, the wrong tool. At worst, it is actively unhelpful — rewarding the thing you should be worried about.
Four things every study glosses over.
Gastric emptying slows in the luteal phase. Progesterone shifts hunger and cravings. Many women report their “bad GLP-1 weeks” line up with the back half of their cycle — and no app knows to ask.
Rapid weight loss triggers telogen effluvium for a meaningful portion of GLP-1 users, showing up around month three to six. It resolves — but only if the body has the protein and micronutrients to grow the hair back.
Women enter adulthood with less lean mass than men and lose it faster in a deficit. A medication that suppresses appetite without protecting protein intake can quietly convert muscle to loss.
GLP-1s are not approved in pregnancy. Tirzepatide can reduce the effectiveness of oral contraceptives. The window between stopping and conceiving is a conversation for your prescriber — but the app can at least raise it.
We ask different questions, so we give different answers.
Steady is cycle-aware by default — not as a feature you have to dig for. It treats protein as the floor, not a line on a macro wheel. It distinguishes logged symptoms from mood and gives you a clean, chronological record your doctor can actually read. And the coach was trained to talk to a woman on a GLP-1 — not to a generic dieter on a generic deficit.
It is a quiet app. It does not send you a push notification when you skip breakfast. It does not ask you to post your progress. It does not celebrate pounds lost with fireworks. It celebrates a protein week held and a symptom that improved.
Four things we will never be.
There is no “Steady plan,” no foods to avoid, no color-coded traffic light on your plate.
We do not diagnose, we do not prescribe, and the coach will tell you so.
There is no timeline of other women’s losses. No leaderboard. No one to perform for.
GLP-1s work over months and years. Steady is built for the long version.
Fertility & GLP-1s — the one-minute version.
GLP-1 medications — semaglutide, tirzepatide, liraglutide — are not approved for use during pregnancy. Most prescribers recommend stopping the medication and waiting at least two months before attempting to conceive.
Tirzepatide can also reduce the effectiveness of oral contraceptives, and a barrier method is often recommended during titration.
These decisions belong to you and your prescriber. Steady is not the place to make them — but it is the place where we will remind you to have the conversation.
The stories of the women Steady is built for.
We will not stage testimonials. When we have real voices to share, they will be here — named and consenting, or anonymous and honest. Until then, the empty space is on purpose.
Be the reason the next app is built right.
Join the waitlist. We’ll email you the day Steady opens on the App Store.